Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Renal Cell × Arsenic Trioxide × Clear all

Sponsor

Conditions

Leukemia, Promyelocytic, Acute 3 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma 1 Skin Neoplasms 1 Sarcoma 1 Retinoblastoma 1 Recurrence 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Medulloblastoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hepatoblastoma 1 Endometrial Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1 Central Nervous System Neoplasms 1 Carcinoma, Small Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1

Interventions

Sunitinib 56 Nivolumab 37 Everolimus 29 Bevacizumab 29 pembrolizumab 24 Sorafenib 23 pazopanib 22 Axitinib 21 aldesleukin 13 Ipilimumab 13 cabozantinib 12 temsirolimus 11 Interferon alpha-2 10 Cyclophosphamide 10 Interleukin-2 9 Radiosurgery 8 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Immunoglobulin G 7 Erlotinib Hydrochloride 7 Disulfides 6 lenvatinib 5 fludarabine phosphate 5 avelumab 5 Radiotherapy 5 Fluorodeoxyglucose F18 5 peginterferon alfa-2b 4 atezolizumab 4 Nephrectomy 4 Interferon-alpha 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡